VANI20260717P3
VANI Jul 17 2026 3.00 Put (VANI260717P00003000)
option OPRA

vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset npm-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.